Advanced Enzyme Technologies (NSE:ADVENZYMES, BOM:540025) said its attributable consolidated profit fell to 376.5 million Indian rupees in the fiscal third quarter from 417.7 million rupees a year ago, according to a filing to the stock exchanges on Saturday by the enzymes and probiotics company.
Earnings per share during the quarter ended Dec 31, 2024, slipped to 3.36 rupees from 3.74 rupees a year earlier.
Revenue from operation in fiscal Q3 increased year on year to 1.69 billion rupees from 1.61 billion rupees, according to the filing.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.